Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHARLA MIXON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1659811057
CMS profile
10776880
Location
HAINES CITY, FL

General Payments · PY2021–2023

$1,195.34

  • Reported across 47 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$291.43

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $291.43 15

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $92.01 5
DEXCOM, INC. $49.51 2
Lilly USA, LLC $39.52 2
Acerta Pharma LLC $33.45 2
Abbott Laboratories $23.48 1
ABBVIE INC. $22.30 1
Bayer HealthCare Pharmaceuticals Inc. $18.29 1
PFIZER INC. $12.87 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $486.56 18
PY2022 $417.35 14
PY2023 $291.43 15

Payment records · PY2023 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $23.48 04/27/2023 Food and Beverage Undisputed 01/23/2026 1018465113 CMS
ABBVIE INC. $22.30 05/19/2023 Food and Beverage Undisputed 01/23/2026 1013713181 CMS
AstraZeneca Pharmaceuticals LP $16.00 01/13/2023 Food and Beverage Undisputed 01/23/2026 1014779937 CMS
AstraZeneca Pharmaceuticals LP $17.45 02/16/2023 Food and Beverage Undisputed 01/23/2026 1011741101 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.29 05/31/2023 Food and Beverage Undisputed 01/23/2026 1005562779 CMS
Dexcom, Inc. $24.62 03/16/2023 Food and Beverage Undisputed 01/23/2026 1054645451 CMS
Dexcom, Inc. $24.89 12/21/2023 Food and Beverage Undisputed 01/23/2026 1054645461 CMS
Lilly USA, LLC $22.87 03/01/2023 Food and Beverage Undisputed 01/23/2026 1032817067 CMS
Lilly USA, LLC $16.65 03/24/2023 Food and Beverage Undisputed 01/23/2026 1032758067 CMS
Novo Nordisk Inc $18.29 02/10/2023 Food and Beverage Undisputed 01/23/2026 1000619219 CMS
Novo Nordisk Inc $21.34 04/18/2023 Food and Beverage Undisputed 01/23/2026 1000619241 CMS
Novo Nordisk Inc $18.46 05/25/2023 Food and Beverage Undisputed 01/23/2026 1000619231 CMS
Novo Nordisk Inc $18.07 06/08/2023 Food and Beverage Undisputed 01/23/2026 1000619211 CMS
Novo Nordisk Inc $15.85 08/04/2023 Food and Beverage Undisputed 01/23/2026 1000602999 CMS
PFIZER INC. $12.87 02/23/2023 Food and Beverage Undisputed 01/23/2026 1050276501 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.